Comments

Greater Cannabis Co (GCAN) Stock Price, Quote, News & History

GCANOTCQB
Logo brought to you by Benzinga Data
Trade with Public
Trade with Public
$0.00020
-0.0831-99.76%
Last update: Jul 23, 9:27 AM

Overview

NewsInsider TradesShort Interest

Key Statistics

Open
-
Close
-
Volume / Avg.
0 / 2.30K
Day Range
- - -
52 Wk Range
0.05 - 3.60
Market Cap
$188.00
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
1.28

Recent Greater Cannabis Company Inc News

Prenatal Cannabis Exposure Not Linked To Elevated Risk Of Autism And Oklahoma Court Rules Pregnant Moms Who Use It Are Not Breaking The Law

Maternal marijuana use is not related to an increased risk of autism spectrum disorder (ASD) in children who were exposed to cannabis in utero. That's according to newly published data in Autism Research earlier this month. The research by experts associated with Emory University, John Hopkins, and Harvard included 11,570 children aged 1–18. The study looked at the correlation between prenatal cannabis exposure and ASD and found no link. "In a large sample and measuring ASD traits continuously, there was no evidence that prenatal cannabis exposure increases the risk for ASD," the researchers concluded. "Although no associations were found with ASD outcomes, prenatal cannabis exposure may still be associated with other facets of child development and behavior that were outside of the scope of this study, such as attention and cognition."
Jelena Martinovic
Partner Content

Cannabis Holds Promise In Treating Autism: GCANRx (OTCPK: GCAN) Is Taking It To The Next Level With Its Novel Neuropsychiatric Cannabinoid Therapy

Can Marijuana Treat Autism, OCD & Irritable Bowel Syndrome? Ohio Medical Panel Will Investigate

Ohio researchers want to learn more about the effects of medical marijuana on those with autism spectrum disorder (ASD), obsessive-compulsive disorder (OCD) and irritable bowel syndrome, reported Cleveland.com.
Jelena Martinovic

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Key Statistics

Open
-
Close
-
Volume / Avg.
0 / 2.30K
Day Range
- - -
52 Wk Range
0.05 - 3.60
Market Cap
$188.00
P/E Ratio
-
Dividend Yield
-
Exchange
OTC
RSI
-
Short Interest
-
Days to Cover
1.28

About

Sector
N/A
Industry
N/A
Greater Cannabis Co Inc is a biopharmaceutical company focused on the development and commercialization of cannabinoid therapeutics. The firm focuses on cannabis-related investment and development opportunities through direct equity investments, join...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
GCAN

FAQ

Q

How do I buy Greater Cannabis Co (GCAN) stock?

A

You can purchase shares of Greater Cannabis Co (OTCQB:GCAN) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Greater Cannabis Co (GCAN) competitors?

A

There are no as such competitors for Greater Cannabis Co.

Q

What is the forecast, or price target, for Greater Cannabis Co (GCAN) stock?

A

There is no analysis for Greater Cannabis Co to provide a consensus price target.

Q

What is the current price for Greater Cannabis Co (GCAN)?

A

The stock price for Greater Cannabis Co (OTCQB: GCAN) is $0.0002 last updated July 23, 2025 at 9:27 AM EDT.

Q

Does Greater Cannabis Co (GCAN) pay a dividend?

A

There are no upcoming dividends for Greater Cannabis Co.

Q

When is Greater Cannabis Co (OTCQB:GCAN) reporting earnings?

A

Greater Cannabis Co does not have any upcoming earnings scheduled.

Q

Is Greater Cannabis Co (GCAN) going to split?

A

There is no upcoming split for Greater Cannabis Co.

Q

What sector and industry does Greater Cannabis Co (GCAN) operate in?

A

Greater Cannabis Co is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the OTCQB.

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2025 Benzinga | All Rights Reserved